Upgrade to SI Premium - Free Trial

Hologic (HOLX) to Acquire Focal Therapeutics for $125 Million

September 26, 2018 4:02 PM
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has signed a definitive agreement to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments Mergers and Acquisitions

Next Articles